Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
Nov 08, 2018 12:30pm EST

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services

Nov 08, 2018 9:12am EST

OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018

Sep 14, 2018 1:33pm EDT

OPKO Confirms Resumption of Common Stock Trading on Nasdaq

Sep 11, 2018 8:30am EDT

OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock

Sep 07, 2018 8:11pm EDT

OPKO Comments on SEC Complaint

Sep 04, 2018 8:00am EDT

OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients

Aug 28, 2018 8:00am EDT

OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial

Aug 07, 2018 4:05pm EDT

OPKO Health Reports Second Quarter 2018 Financial Results

Aug 03, 2018 1:29pm EDT

OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children

Aug 02, 2018 8:00am EDT

OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Page 53
  • Next Pagearrow_forward
rss_feed News RSS

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap